Korro Bio and Frequency Therapeutics to Merge
(24/7 MARKET NEWS) – Frequency Therapeutics, Inc. (NASDAQ:FREQ) and Korro Bio, Inc. reported, this morning, that they entered into a definitive merger agreement to combine the companies in an all-stock transaction. The combined company is expected to have cash balance of approximately $170 million at close, which is expected to provide cash runway through several value-creating milestones and into 2026, and focus on the advancement of Korro Bio’s portfolio of RNA editing programs.
Frequency Therapeutics is trading at $0.58, up $0.18 (+45.00%), up 3.56M premarket shares traded.
Its 52-week range is $0.3258 to $5.59. If it can trade above $1, on stronger trading volume, it has a gap to the $4 level.
24/7 MARKET NEWS, INC Disclaimer
24/7 MARKET NEWS (“24/7 MN”) is dedicated to covering various underreported segments of the stock markets. Our goal is to help you to better understand these markets, but 24/7 MN is neither an investment advisor nor a financial advisor, and no information provided here is to be interpreted as a suggestion to buy or sell stocks or other investment products. All opinions, news, research, analysis, prices or other information contained on 247marketnews.com, its press releases, or other services are provided for educational purposes only and do not constitute investment advice. You are solely responsible for the investment decisions you make.
Please go to 247marketnews.com or https://247marketnews.com/terms-disclaimer/